Peptcell (United Kingdom)
TRx is a clinical-stage drug development company leveraging a proprietary targeted oral drug delivery platform across a growing portfolio of partnered and wholly-owned biopharma products. TRx is utilising natural human biology to access a novel drug uptake channel, so providing an alternative and unexploited mechanism for oral drug absorption compared to both traditional and state-of-the-art oral formulation technologies. TRx’s technology delivers numerous benefits that can be harnessed simultan
Basic Information
- Category: business
- Website: https://seekacure.com/
Documented Facts
- Inception (Wikidata): 2003 (Source 2: Wikidata Q30269216, revision 2474142681)
- Country (Wikidata; date unspecified): United Kingdom (Source 2: Wikidata Q30269216, revision 2474142681; Source 3: Wikidata label: Q145, revision 2554939741)
- Official website (Wikidata; date unspecified): https://seekacure.com/ (Source 2: Wikidata Q30269216, revision 2474142681)
Evidence and Sources
- Peptcell (United Kingdom) — Official Website (official)
- Wikidata Q30269216, revision 2474142681 (knowledge-base)
- Wikidata label: Q145, revision 2554939741 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Peptcell (United Kingdom).
- Canonical profile: https://brandsource.ai/brands/peptcell-united-kingdom
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/peptcell-united-kingdom/json-ld
- Citation profile API: https://brandsource.ai/api/brands/peptcell-united-kingdom/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (91/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
TRx is a clinical-stage drug development company leveraging a proprietary targeted oral drug delivery platform across a growing portfolio of partnered and wholly-owned biopharma products. TRx is utilising natural human biology to access a novel drug uptake channel, so providing an alternative and unexploited mechanism for oral drug absorption compared to both traditional and state-of-the-art oral formulation technologies. TRx’s technology delivers numerous benefits that can be harnessed simultan
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.